Sintx Technologies (SINT) to Release Earnings on Friday

Sintx Technologies (NASDAQ:SINT) will likely be releasing its results before the market opens on Friday, May 15th. Analysts expect Sintx Technologies to post earnings of ($0.66) per share and revenue of $0.30 million for the quarter.

Sintx Technologies Stock Performance

NASDAQ SINT opened at $2.40 on Wednesday. The stock has a fifty day moving average of $2.59 and a 200-day moving average of $3.15. The stock has a market capitalization of $9.89 million, a P/E ratio of -0.42 and a beta of 0.61. Sintx Technologies has a 52 week low of $1.99 and a 52 week high of $6.78.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on SINT. HC Wainwright began coverage on Sintx Technologies in a research note on Monday, April 13th. They issued a “buy” rating and a $10.00 target price for the company. Weiss Ratings restated a “sell (e+)” rating on shares of Sintx Technologies in a research report on Tuesday, April 21st. Finally, Ascendiant Capital Markets reduced their price target on Sintx Technologies from $16.00 to $12.00 and set a “buy” rating on the stock in a research report on Wednesday, April 8th. Two research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, Sintx Technologies has a consensus rating of “Hold” and an average price target of $11.00.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in Sintx Technologies stock. Geode Capital Management LLC boosted its holdings in shares of Sintx Technologies, Inc. (NASDAQ:SINT) by 53.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 26,624 shares of the company’s stock after acquiring an additional 9,265 shares during the period. Geode Capital Management LLC owned approximately 0.72% of Sintx Technologies worth $103,000 as of its most recent filing with the Securities and Exchange Commission. Hedge funds and other institutional investors own 18.38% of the company’s stock.

About Sintx Technologies

Sintx Technologies, Inc (NASDAQ: SINT) is a medical materials company specializing in the development and manufacture of silicon nitride-based biomaterials for surgical and implantable medical devices. Its proprietary silicon nitride ceramic combines mechanical strength, biocompatibility and intrinsic antimicrobial properties, positioning it as an alternative to traditional metal and polymer implant materials. Sintx’s primary focus is on applications in spinal fusion, trauma fixation and dental implantology, where device performance and long-term biological response are critical.

The company’s core product offerings include silicon nitride powders for advanced implant fabrication and finished implantable components designed for interbody spinal fusion cages, spinal fixation hardware and trauma plates and screws.